… of venousthromboembolism were not included in this analysis. A prior systematic review and network meta-analysis … for the secondary prevention of venousthromboembolism has been …
A Iorio, F Guercini, M Pini - Journal of Thrombosis and Haemostasis, 2003 - Elsevier
Background: The management of venousthromboembolism (VTE) requires an initial treatment with unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH), followed by …
Background: The potential risk for travel-related venousthromboembolism (VTE) has become an important public health concern because of rapid increases in long-distance travel; …
… venousthromboembolism prevention trials to evaluate the causal effect of venous thromboembolism … the use of composite endpoints in venousthromboembolism-prevention trials …
F Horsted, J West, MJ Grainge - 2012 - journals.plos.org
Background People with cancer are known to be at increased risk of venousthromboembolism (VTE), and this risk is believed to vary according to cancer type, stage of disease, and …
D Ost, J Tepper, H Mihara, O Lander, R Heinzer, A Fein - Jama, 2005 - jamanetwork.com
ContextPatients with venousthromboembolism (VTE) are susceptible to recurrent events, but whether prolonging anticoagulation is warranted in patients with VTE remains controversial…
… higher risk of recurrent venousthromboembolism in men than in women we did a meta-analysis of all relevant available evidence. A secondary objective of this analysis was to look for …
Venousthromboembolism, comprising both deep vein thrombosis and pulmonary embolism, is a chronic illness that affects nearly 10 million people every year worldwide. Strong …
JG Ray, D Shmorgun, WS Chan - Pathophysiology of haemostasis and …, 2002 - karger.com
… of hyperhomocysteinemia, its correlation with venousthromboembolism (VTE) remains controversial. We conducted a meta-analysis of previously published studies to clarify the role of …